crafted rx semaglutide An Update on the Status

2017 Ozempic (semaglutide) is approved for Type 2 diabetes

We recommend that all patients should be asked about glucagon-like peptide-1 receptor agonist (GLP-1RA) and dual GLP-1 and glucose-dependent insulinotropic polypeptide receptor co-agonist (GLP-1/GIPRA) use prior to anaesthesia or sedation for surgical and endoscopic procedures and be informed of the benefits and risks

This combination has not been approved by regulatory authorities and could potentially amplify side effects including gastrointestinal disturbances and cardiovascular risks

Alongside their rapid rise in popularity, misinformation has also increased